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Micro-injection of, or incubation with okadaic acid (OA), a specific phosphatase inhibitor, can induce formation of matu- 
ration-promoting factor (MPF) and germinal vesicle breakdown (GVBD) in Xenopus laevis oocytes. Comparison of the 
dose-response curves of OA on maturation, isolated enzymes and phosphatase activities in crude oocyte preparations 
suggests that inhibition of both polycation-stimulated (PCS) and ATP,Mg-dependent (AMD) phosphatases i sufficient 
but requires that a critical phosphorylation level is attained of one or several of their substrates, resulting in the formation 
of active MPF and meiotic maturation. 
Okadaic acid; Oocyte maturation; Protein phosphatase 
1. INTRODUCTION 
The concept that phosphorylation processes are 
implicated in the regulation of the cell cycle gained 
new impetus with the discovery that highly purified 
preparations of MPF from Xenopus oocytes con- 
tain a protein kinase activity which appears to be 
the Xenopus homologue of the cdc2 gene product 
of the fission yeast Schizosaccharomyces pombe 
[1,2]. The human cdc2 gene, as well as yeast cdc2, 
encodes a 34 kDa protein kinase [3]. The cyclic rise 
and fall of MPF activity during the cell cycle is ap- 
parently due to posttranslational modification 
rather than de novo synthesis [4,5]. The transition 
between inactive pre-MPF and active MPF could 
be due to inactivation of a protein phosphatase [5] 
and it has been shown by genetic analysis and se- 
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quencing, that genes coding for protein kinases 
[6,7] can act as positive and negative effecters of 
p34cdc2, implicating protein phosphorylation in 
MPF regulation. In addition, subunit rear- 
rangements appear to be involved in activation of 
the ~34’~” kinase in human cells [B]. The ap- 
pearance of MPF activity leads ultimately to a ma- 
jor burst in protein phosphorylation, approximate- 
ly coincident with the GVBD [9]. Several distinct 
protein kinase activities are enhanced at the time of 
the appearance of MPF [lo], e.g. ribosomal pro- 
tein SS kinase II [l l] and independent histone 
kinase [12]. The major 34 kDa band in highly 
purified independent histone kinase from starfish 
oocytes was identified as the ~34’~‘~ kinase [ 131. 
The concept of protein kinase cascades certainly 
is familiar in the field of protein phosphorylation, 
but protein kinases and phosphatases represent an 
intertwining network requiring efficient coordina- 
tion of both activities. Only a small number of 
multifunctional phosphatases appear to control the 
major regulatory proteins. Four different types of 
Ser/Thr protein phosphatases can be distinguished 
[ 14- 161, classified according to enzyme-directed 
regulation [ 161 as PCS phosphatases, AMD 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 91 
Volume 245, number 1,2 FEBS LETTERS March 1989 
phosphatases, calcineurin and Mg2+-dependent 
protein phosphatase. The PCS and AMD 
phosphatases appear to be highly regulated en- 
zymes and the former could play a central role in 
cellular regulation [17], since they are involved in 
the regulation of AMD phosphatase, phosphoryl- 
ase kinase, casein kinase 2, protein kinase C and 
ribosomal protein SS kinase, etc. In addition, they 
can be converted from a Ser/Thr phosphatase into 
a Tyr protein phosphatase [18-201. The lack of a 
specific inhibitor was a hindrance in the study of 
the in vivo role of PCS phosphatase. Okadaic acid 
[21], a strong inhibitor of AMD and PCS phos- 
phatases 1221, is also a strong non-TPA-like tumor 
promoter [23]. Its acute effect on intestine smooth 
muscle contraction was ascribed to specific inhibi- 
tion of myosin light chain phosphatase activity 
[24,25]. Phosphorylation/dephosphoryladon pro- 
cesses are believed to be the driving force in regula- 
tion of the cell cycle. We further substantiate this 
concept, showing that microinjection of, or in- 
cubation with OA, a specific phosphatase in- 
hibitor, can induce MPF formation and germinal 
vesicle breakdown (GVBD) in X. luevis oocytes. 
Comparison of dose-response curves of OA on 
maturation, isolated enzymes and phosphatase ac- 
tivities in crude oocyte preparations suggests that 
inhibition of both PCS and AMD phosphatases i  
required to reach a critical phosphorylation level of 
one or several of their substrates. Since OA is also 
recognized as a tumor promoter [23], it is tempting 
to speculate as to the role of phosphatases in cell 
proliferation in general. 
2. MATERIALS AND METHODS 
Different dilutions of OA were prepared from a 2.5 mM stock 
solution in dimethyl sulfoxide. Oocytes were prepared as 
described in [18], and the different oligomeric forms of PCS 
phosphatases (PC&, PC!&+ PC&) were purified to 
homogeneity from rabbit skeletal muscle [26], and the PCSL 
phosphatase also from Xenopus oocytes [18]. The catalytic 
subunit of the PCS phosphatases (PCSc phosphatase) and the 
AMD phosphatase was purified from rabbit skeletal muscle [27] 
and that of the AMD phosphatase also from dog liver [28]. The 
inactive form of AMD phosphatase was purified from rabbit 
skeletal muscle and activated as described [29], the deinhibitor- 
stimulated form of the AMD phosphatase being from dog liver 
as described previously [30]. Myosin light chains were prepared 
as in [31]. Tyrosine kinase was purified to apparent homogenei- 
ty from the particulate fraction of pig spleenbased on a previous 
procedure as modified; the method is detailed in [32]. The 
purification includes detergent extraction, DEAE-Sephacel, 
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tyrosine agarose, heparin-Sepharose and Mono Q-FPLC 
chromatography. This procedure was designed with particular 
care being taken to eliminate endogenous aryl phosphatases. 
Kinase activity was followed using the synthetic peptide 
poly[Glu:Tyr] (4:l) (Sigma) as substrate. The final preparation 
could incorporate 109 nmol Pi/min per mg in this substrate and 
showed an autophosphorylating protein doublet of 55 kDa in 
SDS-PAGE. Phosphatase assays were performed with 
phosphorylase as substrate according to [33] unless stated other- 
wise, and pNPP phosphatase as in [18]. Phosphotyrosyl 
phosphatase activity was assayed with 0.3 PM phosphomyosin 
light chains, phosphorylated exclusively on phosphotyrosyl 
residues to a level of 0.05 mol/mol by the porcine spleen 
tyrosine kinase (see above), as monitored by thin-layer elec- 
trophoresis at pH 3.5 after acid hydrolysis as in [34]. 
3. RESULTS AND DISCUSSION 
In the absence of any other physiological 
stimulus, microinjection of OA can induce GVBD 
and formation of active MPF within 30-60 min. 
The dose-response curve of OA-induced GVBD 
(fig.1) shows that maturation of 50% of the 
oocytes is obtained by injection of 50 nl of 2.5 PM 
OA. Assuming rapid distribution of OA, and a 
volume of 500 nl for the cytosolic compartment, 
this represents an intracellular concentration of 
about 0.25 pM. Initiation of GVBD was very rapid 
(30-60 min) compared with progesterone-induced 
(4-7 h) and MPF-induced (90-120 min) matura- 
tion. Oocytes not matured within 60 min did not 
mature afterwards. The reaction of the oocyte to 
OA was rather violent, resulting in an irregular 
white spot on the animal pole followed by rapid 
cytolysis (within 15 min). The germinal vesicle 
disappeared, within 60 min, as confirmed on 
dissection of oocytes after fixation in 10% 
trichloroacetic acid. As soon as the white spot ap- 
peared, cytoplasm ( f 50 nl) was transferred to 2-4 
recipient oocytes, which showed MPF-induced 
maturation in 100% of cases, through the ap- 
pearance of the typical white spot within 90-120 
min and GVBD as confirmed upon dissection after 
trichloroacetic acid fixation. This secondary 
maturation was not caused by OA still present after 
the transfer, without formation of MPF. Indeed, 
the steep dose-response curve of the OA-induced 
maturation (fig. 1) implies that OA, at the expected 
low concentrations, cannot induce maturation. In 
addition, the difference in maturation time and the 
appearance of normal secondary maturation, in 
contrast with the atypical maturation induced by 
OA, indicate the involvement of a different 
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Fig. 1. Dose-response curve of okadaic acid-induced matura- 
tion. Batches of 10 oocytes prepared as in [18] were microin- 
jetted with 50-nl dilutions of OA dissolved in 10 mM Hepes, 
5 mM dithiothreitol, 1 mg/ml bovine serum albumin (pH 7.4), 
prepared from a stock solution of 2.5 mM OA in dimethyl 
sulfoxide. Maturation was scored between 30 and 60 min after 
microinjection and confirmed by dissection after trichloroacetic 
acid fixation. 
mechanism. The transfer from matured recipient 
oocytes into third generation recipient oocytes fur- 
ther substantiates the formation of authentic MPF. 
When oocytes were incubated in different concen- 
trations of OA (75 PM-2.5 nM), maturation was 
observed between 25 and 50 /cM. Maturation in 
these cases was much less violent and slower than 
after microinjection of OA. The time course of 
maturation was descreased compared to 
progesterone-induced maturation. GVBDso was at- 
tained within 4 h with progesterone and within 3 h 
with 50 PM OA. With slowly maturing oocytes 
(GVBDSO 6 h with progesterone), this time was 
reduced to 3 h in the presence of 50 ,uM OA. 
We investigated the inhibitory effect of OA on 
the oligomeric forms of homogeneously purified 
PCS [26] and AMD [27,28] phosphatases, as well 
as on their respective catalytic subunits [29,30]. 
The values for 50% inhibitory concentration ob- 
tained with PCS phosphatases were between 10 and 
500 pM (PC& < PCSc = PC&. < PC&), also 
depending on the enzyme concentrations in the 
assay, and between 80 and 200 nM for AMD phos- 
phatases. The pronounced inhibition by OA 
observed with PCS phosphatases is clearly at 
variance with observations for PCM phosphatase 
in [22]. However, the PCM phosphatase was 
shown to be a mixture of PCS and AMD phos- 
phatases 1261. 
The microenvironment, aspecific binding, effec- 
tor metabolism, etc. could largely influence the 
sensitivity of the different phosphatases in vivo. 
Therefore, the effect of OA on phosphorylase 
phosphatase activity was also ascertained in crude 
oocyte fractions under conditions allowing selec- 
tive expression of PCS and AMD phosphatase ac- 
tivities [33]. Basically the same picture emerges as 
with the purified enzymes: under these conditions 
the AMD phosphatase (particulate fraction in- 
cubated in the presence of deinhibitor protein and 
pNPP), displayed an 40 of 80 nM, that of the PCS 
phosphatase (high-speed supernatant incubated 
with protamine) being 2 nM. 
Because of the importance of Tyr phosphoryla- 
tion in signal transduction and since the Tyr-phos- 
phatase activity associated with PCS phosphatases 
can be regulated [17-201 and represents a signifi- 
cant fraction of soluble Tyr-phosphatase activity in 
oocytes [19], we tested the effect of OA on this ac- 
tivity using pNPP or myosin light chains phos- 
phorylated on Tyr residues. An ISO of 1 nM was 
determined for both ATP-stimulated PTPase and 
pNPPase activity of the PC& phosphatase and ISO 
values of 2 and 5 nM were noted for the basal 
PTPase and pNPPase activity, respectively, 
somewhat greater than those observed with phos- 
phorylase a as substrate. 
OA at concentrations up to 10pM was without 
effect on commercially available E. coli alkaline 
phosphatase (type III-R, Sigma). Since the ISO for 
calcineurin is 10pM [22], whereas the 
Mg2+-stimulated phosphatase is unaffected by OA 
at the same concentration [22], the inhibitory effect 
of OA on isolated phosphatases in the low concen- 
tration range (c 1 PM) seems to be limited to the 
PCS and AMD phosphatases. 
4. CONCLUSIONS 
Our results suggest hat a critical phosphoryla- 
tion level of one (or several) protein(s) is sufficient 
but required to initiate meiotic maturation and 
convert pre-MPF into active MPF in Xenopus 
oocytes. The dose-response curves indicate that, at 
least in one link of the chain of events leading to 
meiosis induced by OA, inhibition of both PCS 
and AMD phosphatases is required. Our ex- 
periments do not exclude the possible involvement 
of the PCS and/or AMD phosphatases in signal 
transduction of other mitotic agents such as pro- 
gesterone. In the presence of OA, the kinase/phos- 
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phatase equilibrium at the substrate level might be 
completely in favor of the kinase so that kinase ac- 
tivation (possibly by dephosphorylation) is no 
longer required to obtain a critical level of sub- 
strate phosphorylation. The very short maturation 
time indeed suggests that other processes could be 
bypassed. The high affinity of OA for PCS phos- 
phatases implies that these enzymes could function 
as the receptor for OA in vivo. The fact that a 
tumor promoter is an inhibitor of protein phos- 
phatases constitutes a challenge in further in- 
vestigations of the importance of these enzymes in 
cellular control. 
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